Institutional Ownership
Ernexa Therapeutics Inc
CUSIP 114082118*W EXP 02/04/203Q1 2026
13D / 13G Filings
0
Schedule 13D/13G on record
Beneficial Filers
0
Distinct reporting persons
Largest Stake
—
Max % of class reported
Institutional Holders
5
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
Schedule 13D (activist) & 13G (passive) 5%+ ownership filings
No 13D/13G filings on record yet
Schedule 13D/13G beneficial-ownership filings from 2020–present are ingested from SEC EDGAR. Coverage expands as the backfill and daily crawler run.
Top Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Armistice Capital, LLC | 4.00M | $112.0K |
| 2 | Bleichroeder LP | 2.00M | $56.0K |
| 3 | Heights Capital Management, Inc | 400.0K | $16.0K |
| 4 | Warberg Asset Management LLC | 253.8K | $7.1K |
| 5 | Clear Street Group Inc. | 149.3K | $4.2K |